LX3305
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for LX3305, covering 2010-06-03 to 2012-08-02. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Determine the Safety and Efficacy of LX3305 in Subjects With Active Rheumatoid Arthritis [Phase 1]